Catherine Coste - 24 Feb 2026 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Director
Signature
/s/ Catherine Coste
Issuer symbol
BLFS
Transactions as of
24 Feb 2026
Net transactions value
$0
Form type
4
Filing time
26 Feb 2026, 17:55:54 UTC
Previous filing
20 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coste Catherine Director 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL /s/ Catherine Coste 26 Feb 2026 0001821432

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Award +8,170 +143% 13,871 24 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026.